Even so, in an interview with The Economist, Mr Doustdar sounded confident that Novo can recover. His prescription is to push ...

Tom Standage, editor of The World Ahead, and Alex Hern, our AI writer, consider the technologies to watch in the coming year.

From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to ...

Thousands of low-income Pennsylvanians will face new barriers to weight-loss drugs like Ozempic under a move quietly ...

In January, Trump RX is scheduled to launch. It will allow people to bypass insurers and other middlemen, and buy discounted drugs directly from manufacturers..

The implications from the design of the clinical GLP-1 agonist trials and studies of caloric restriction are that exercise is ...

Citing topline data from its Phase 3 TRIUMPH-4, the Indiana-based drugmaker said that retatrutide, a GIP, GLP-1, and glucagon triple hormone receptor agonist, at the two highest doses led to ...

New research reveals that taking a GLP-1 can be equivalent to '10 years of ageing' on the body, if proper precautions aren't taken ...

President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 ...

Oprah Winfrey is staying active while traveling the world. On Dec. 12, the former talk show host, 71, shared a photo of ...

Amy Schumer reveals her dramatic 50-pound weight loss was due to life-threatening Cushing's syndrome. Here's what to know ...

Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...